Connor, Clark & Lunn Investment Management (CC&L)’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29M | Buy |
191,268
+166,429
| +670% | +$25.3M | 0.1% | 177 |
|
|
2025
Q1 | $3.74M | Buy |
+24,839
| New | +$3.74M | 0.02% | 576 |
|
|
2024
Q1 | – | Sell |
-17,027
| Closed | -$4.03M | – | 1553 |
|
|
2023
Q4 | $4.03M | Buy |
+17,027
| New | +$4.03M | 0.02% | 490 |
|
|
2022
Q3 | – | Sell |
-16,923
| Closed | -$3.62M | – | 1131 |
|
|
2022
Q2 | $3.62M | Sell |
16,923
-9,110
| -35% | -$1.95M | 0.02% | 370 |
|
|
2022
Q1 | $7.39M | Sell |
26,033
-18,986
| -42% | -$5.39M | 0.04% | 262 |
|
|
2021
Q4 | $17M | Buy |
45,019
+19,233
| +75% | +$7.25M | 0.08% | 182 |
|
|
2021
Q3 | $10.6M | Buy |
25,786
+18,446
| +251% | +$7.61M | 0.06% | 236 |
|
|
2021
Q2 | $2.72M | Buy |
+7,340
| New | +$2.72M | 0.01% | 482 |
|
|
2020
Q2 | – | Sell |
-8,396
| Closed | -$1.06M | – | 1045 |
|
|
2020
Q1 | $1.06M | Buy |
+8,396
| New | +$1.06M | 0.01% | 549 |
|
|
2019
Q1 | – | Sell |
-2,200
| Closed | -$249K | – | 934 |
|
|
2018
Q4 | $249K | Buy |
+2,200
| New | +$249K | ﹤0.01% | 815 |
|
|
2018
Q2 | – | Sell |
-6,575
| Closed | -$702K | – | 1047 |
|
|
2018
Q1 | $702K | Buy |
+6,575
| New | +$702K | ﹤0.01% | 527 |
|
|
2017
Q4 | – | Sell |
-10,400
| Closed | -$1.12M | – | 794 |
|
|
2017
Q3 | $1.12M | Buy |
+10,400
| New | +$1.12M | 0.01% | 511 |
|
|
2016
Q4 | – | Sell |
-3,300
| Closed | -$275K | – | 901 |
|
|
2016
Q3 | $275K | Buy |
+3,300
| New | +$275K | ﹤0.01% | 689 |
|
|
2014
Q4 | – | Sell |
-17,500
| Closed | -$1.05M | – | 595 |
|
|
2014
Q3 | $1.05M | Buy |
17,500
+3,900
| +29% | +$233K | 0.01% | 295 |
|
|
2014
Q2 | $775K | Buy |
+13,600
| New | +$775K | 0.01% | 346 |
|
|
2013
Q3 | – | Sell |
-5,300
| Closed | -$229K | – | 537 |
|
|
2013
Q2 | $229K | Buy |
+5,300
| New | +$229K | ﹤0.01% | 459 |
|